AMH is a protein hormone made by granulosa cells in small ovarian follicles. Because these early-stage follicles each contain an immature egg, AMH in the bloodstream reflects the size of your ovarian reserve - how many egg-containing follicles remain available for potential ovulation. AMH is relatively stable day to day compared with cycle-dependent hormones, making it a useful snapshot of ovarian function, fertility potential, and ovarian aging at a given time.

An AMH test estimates ovarian reserve by measuring AMH produced by small follicles in the ovaries. Higher AMH generally indicates more small follicles, while lower AMH suggests fewer remaining egg-containing follicles (diminished ovarian reserve). Because AMH tends to be stable across the menstrual cycle, it can help guide fertility planning, predict response to ovarian stimulation in fertility treatment, and provide insight into the narrowing fertility window as AMH naturally declines with age.

AMH is secreted by early-stage follicles and does not fluctuate as dramatically with cycle timing as some other reproductive hormones. The page context notes that AMH remains relatively stable from day to day, making it a reliable snapshot of ovarian reserve at any point in the cycle. For fuller interpretation, AMH is best viewed alongside FSH, estradiol, and your menstrual pattern rather than used as a standalone marker.

Low AMH usually indicates diminished ovarian reserve, meaning fewer egg-containing follicles remain. This can shorten the fertile window, lower chances of conception, and may signal earlier menopause risk - even if cycles still look regular. Low AMH commonly occurs with normal aging (often accelerating after the mid-thirties) but can also be seen earlier due to genetics, autoimmune ovarian conditions, prior chemotherapy or radiation, or ovarian tissue removal.

High AMH usually reflects an increased number of small follicles in the ovaries and is most commonly associated with polycystic ovary syndrome (PCOS). In PCOS, many small follicles accumulate, which can disrupt ovulation and contribute to irregular periods. Elevated AMH in this context may occur alongside higher androgens and insulin resistance, and PCOS can also carry longer-term metabolic and cardiovascular risks.

“Optimal” AMH generally means your ovarian reserve appears consistent with your age and reproductive stage, not that you’ve hit a single ideal number. AMH declines steadily from birth through menopause, so healthy values are highly age-dependent. Interpretation also depends on lab methods, since assays can vary, making cross-lab comparisons tricky. For best context, review AMH together with age, symptoms, menstrual pattern, and other labs like FSH and estradiol.

AMH testing can support family planning by estimating ovarian reserve and helping identify whether your fertility window may be shorter or more extended. Lower AMH may suggest considering earlier attempts at conception or discussing options like egg freezing sooner, while higher AMH may indicate a larger pool of small follicles. AMH can also help clinicians anticipate response to ovarian stimulation during fertility treatment, supporting more informed planning with your doctor.

The context states AMH is stable across the menstrual cycle and is unaffected by hormonal contraceptives in most studies. That means many people can test AMH without carefully timing the cycle day. However, interpretation should still be individualized and age-based. Because lab methods vary, it’s also important to use the same laboratory if you plan to track AMH over time to monitor ovarian function changes.

AMH is one of the most direct indicators of ovarian reserve, but it’s best interpreted alongside FSH, estradiol, and menstrual pattern for a fuller clinical picture. AMH reflects the remaining pool of egg-containing follicles, while other hormones and cycle patterns help clarify overall ovarian function, ovulatory status, and endocrine balance. Using multiple markers together can improve decision-making for fertility treatment planning and for understanding changes related to age or medical treatments.

Yes. The context notes AMH is produced by ovaries in women and testes in men, and it can help assess testicular function and sexual development in men and children. Interpretation differs by sex and age: in men, AMH is normally low after puberty, so “low AMH” doesn’t mean the same thing as diminished ovarian reserve. In women of reproductive age, AMH primarily serves as a marker of ovarian reserve and ovarian aging.